Accolade, Inc. (ACCD)

NASDAQ: ACCD · IEX Real-Time Price · USD
9.96
-0.29 (-2.83%)
Mar 1, 2024, 4:00 PM EST - Market closed
-2.83%
Market Cap 770.98M
Revenue (ttm) 388.49M
Net Income (ttm) -122.73M
Shares Out 77.41M
EPS (ttm) -1.61
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 498,207
Open 10.30
Previous Close 10.25
Day's Range 9.88 - 10.33
52-Week Range 6.33 - 17.01
Beta 2.15
Analysts Strong Buy
Price Target 15.77 (+58.33%)
Earnings Date Apr 25, 2024

About ACCD

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialis... [Read more]

Sector Healthcare
IPO Date Jul 2, 2020
Employees 2,370
Stock Exchange NASDAQ
Ticker Symbol ACCD
Full Company Profile

Financial Performance

In 2022, Accolade's revenue was $363.14 million, an increase of 17.13% compared to the previous year's $310.02 million. Losses were -$459.65 million, 273.3% more than in 2021.

Financial Statements

Analyst Forecast

According to 13 analysts, the average rating for ACCD stock is "Strong Buy." The 12-month stock price forecast is $15.77, which is an increase of 58.33% from the latest price.

Price Target
$15.77
(58.33% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Accolade To Present at Upcoming Investor Conferences

SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences:

4 days ago - GlobeNewsWire

Accolade Welcomes Brightline to Trusted Partner Ecosystem

Partnership expands access to high-quality, affordable adolescent and children's behavioral health services SEATTLE , Feb. 27, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today that B...

5 days ago - PRNewsWire

Accolade Welcomes Kindbody to Trusted Partner Ecosystem

Kindbody partnership builds on Accolade's commitment to offer best-in-class women's health, fertility and family-forming capabilities for customers and members SEATTLE , Jan. 23, 2024 /PRNewswire/ -- ...

5 weeks ago - PRNewsWire

CNET Bestows ‘Best of Internet Providers of 2024' accolade to Kinetic

LITTLE ROCK, Ark.--(BUSINESS WIRE)--Technology and consumer electronics website CNET has bestowed its “Best of” accolade on Kinetic as the “Best for Fast DSL Internet Speeds.” This is the second conse...

5 weeks ago - Business Wire

Accolade Announces Results for Fiscal Third Quarter 2024

SEATTLE, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2023.

7 weeks ago - GlobeNewsWire

Avenir LNG secures time charter extensions for Avenir Advantage and Avenir Accolade

LONDON, January 04, 2023 – Avenir LNG Limited (“Avenir”) today announces it has executed two Time Charter Agreements for the Avenir Advantage and the Avenir Accolade.

2 months ago - GlobeNewsWire

License Global Releases 2023 Annual Accolade, The Influentials

SANTA MONICA, CA / ACCESSWIRE / December 7, 2023 / License Global, the premier publication and leading source of news and trends for the global consumer product and licensing industries, has released ...

3 months ago - Accesswire

Accolade To Present at Piper Sandler 35th Annual Healthcare Conference

SEATTLE, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Piper Sandler 35th An...

3 months ago - GlobeNewsWire

Accolade Announces Repurchase of $76.5 Million of 0.50% Convertible Senior Notes Due 2026

SEATTLE, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it has entered into separate, privately negotiated transactions with certain holders of its outstanding 0....

3 months ago - GlobeNewsWire

Accolade To Present at Stephens Annual Investment Conference

SEATTLE, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Stephen Annual Invest...

4 months ago - GlobeNewsWire

Accolade Named to 2023 Deloitte Technology Fast 500™

Attributes 227% revenue growth to a relentless focus on delivering exceptional outcomes SEATTLE , Nov. 8, 2023 /PRNewswire/ -- Accolade today announced it has been named to the Deloitte Technology Fas...

4 months ago - PRNewsWire

GLP-1 Coverage in Employer Plans Could Nearly Double in 2024

Employer survey: 25% of employers currently offer coverage and most experience positive outcomes; 4 in 10 consider it an immediate concern and intend to offer in 2024; while 21% of HR decision-makers ...

5 months ago - PRNewsWire

Accolade Announces Results for Fiscal Second Quarter 2024

SEATTLE, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2023.

5 months ago - GlobeNewsWire

Accolade to Announce Fiscal Second Quarter 2024 Financial Results

SEATTLE, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal second quarter 2024 financ...

5 months ago - GlobeNewsWire

Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience

Welcomes Dr. Connie Hwang as chief medical officer, creates roles of chief health officer and chief nursing officer SEATTLE , Sept. 18, 2023 /PRNewswire/ -- Accolade (Nasdaq: ACCD) announced the expan...

5 months ago - PRNewsWire

CORRECTING and REPLACING -- Accolade To Present at Upcoming Investor Conferences

SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Sept. 5, 2023 by Accolade, Inc. (NASDAQ: ACCD), please note that in the second bullet, the time of the Morgan...

6 months ago - GlobeNewsWire

Named as a Top Edge Computing Company to Watch in 2023: FusionLayer Receives an Accolade for Its Hybrid Edge Networking Vision

HELSINKI--(BUSINESS WIRE)-- #MEC--FusionLayer Inc. has been featured as one of the top Edge Computing companies to watch in 2023 in the latest edition of Insights Success magazine. With an impressive ...

6 months ago - Business Wire

Chargeback Gurus Nabs Industry Accolade by The Digital Banker

PLANO, Texas--(BUSINESS WIRE)--Chargeback Gurus (CBG), an industry leader in chargeback prevention and revenue recovery solutions, today announced it has been named the Best Payments Solution by a Ven...

6 months ago - Business Wire

Masan reinforces its brand through significant domestic and international accolade

Through ongoing winning awards, Masan strengthens its esteemed brand Masan reinforces its brand through significant domestic and international accolades. Masan's strong dedication to shareholders and ...

6 months ago - PRNewsWire

Accolade: A Rising Personalized AI-Powered Healthcare Platform

Accolade Inc. NASDAQ: ACCD is an artificial intelligence (AI) powered healthcare platform that provides personalized healthcare guidance for employers and workers. The platform helps people manage the...

8 months ago - MarketBeat

Accolade Announces Results for Fiscal First Quarter 2024

SEATTLE, June 29, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2023.

8 months ago - GlobeNewsWire

Accolade to Announce Fiscal First Quarter 2024 Financial Results

SEATTLE, June 13, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal first quarter 2024 financia...

9 months ago - GlobeNewsWire

Equip Partnership Adds Eating Disorder Support to Accolade's Trusted Partner Ecosystem

Accolade and Equip offer employers purpose-built integrations to address barriers to eating disorder treatment. SEATTLE , June 7, 2023 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the company that p...

9 months ago - PRNewsWire

Report: Employees are Overwhelmed, Delaying Care at High Rates

New health trends report explores causes of stress and offers solutions, including virtual care expansion and enhanced health equity. SEATTLE , June 5, 2023 /PRNewswire/ -- Accolade (Nasdaq: ACCD), th...

9 months ago - PRNewsWire

Accolade To Present at Stifel 2023 Cross Sector Insight Conference

SEATTLE, June 01, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Stifel 2023 Cross Sec...

9 months ago - GlobeNewsWire